2-27025376-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBS1BS2
The NM_012326.4(MAPRE3):c.470-207C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0014 in 152,352 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0014 ( 6 hom., cov: 33)
Consequence
MAPRE3
NM_012326.4 intron
NM_012326.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.40
Publications
1 publications found
Genes affected
MAPRE3 (HGNC:6892): (microtubule associated protein RP/EB family member 3) The protein encoded by this gene is a member of the RP/EB family of genes. The protein localizes to the cytoplasmic microtubule network and binds APCL, a homolog of the adenomatous polyposis coli tumor suppressor gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.0014 (213/152352) while in subpopulation EAS AF = 0.0388 (201/5174). AF 95% confidence interval is 0.0345. There are 6 homozygotes in GnomAd4. There are 115 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 213 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAPRE3 | NM_012326.4 | c.470-207C>T | intron_variant | Intron 4 of 6 | ENST00000233121.7 | NP_036458.2 | ||
MAPRE3 | NM_001303050.2 | c.470-207C>T | intron_variant | Intron 4 of 6 | NP_001289979.1 | |||
MAPRE3 | NM_001410716.1 | c.425-207C>T | intron_variant | Intron 4 of 6 | NP_001397645.1 | |||
MAPRE3 | XM_047443728.1 | c.470-207C>T | intron_variant | Intron 4 of 6 | XP_047299684.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00140 AC: 213AN: 152234Hom.: 6 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
213
AN:
152234
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.00140 AC: 213AN: 152352Hom.: 6 Cov.: 33 AF XY: 0.00154 AC XY: 115AN XY: 74500 show subpopulations
GnomAD4 genome
AF:
AC:
213
AN:
152352
Hom.:
Cov.:
33
AF XY:
AC XY:
115
AN XY:
74500
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41584
American (AMR)
AF:
AC:
6
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3466
East Asian (EAS)
AF:
AC:
201
AN:
5174
South Asian (SAS)
AF:
AC:
5
AN:
4834
European-Finnish (FIN)
AF:
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
0
AN:
68036
Other (OTH)
AF:
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
10
21
31
42
52
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
76
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.